EP2911623
Augnkerfi fyrir forðalosun á lyfi í auga
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.10.2013EP published:
14.8.2019EP application number:
13786598.6
EP translation filed:
4.11.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
24.10.2033Expiry date:
24.10.2024
Title:
OPHTHALMIC SYSTEM FOR SUSTAINED RELEASE OF DRUG TO EYE
Timeline
Today
25.10.2013EP application
14.8.2019EP Publication
4.11.2019Translation submitted
15.11.2019Registration published
24.10.2024Expires
Owner
Name:
Forsight Vision5, Inc.Address:
5 Giralda Farms, Madison, NJ 07940, US
Inventor
Name:
RUBIN, Anne, BrodyAddress:
Menlo Park, CA, US
Name:
ALSTER, YairAddress:
Menlo Park, CA, US
Name:
REICH, Cary, J.Address:
Menlo Park, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261719144 PDate:
26.10.2012Country:
US
Classification
Categories:
A61F 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.10.2019
Expires: 24.10.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.10.2020
Expires: 24.10.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 14.9.2021
Expires: 24.10.2022
Payer: Örn Þór slf.
Number: 10
Paid: 14.9.2022
Expires: 24.10.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 25.9.2023
Expires: 24.10.2024
Payer: Árnason Faktor ehf.